EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients ...
Technologies Corporation (NASDAQ:NMTC), a medical technology firm specializing in neurological surgical solutions with a market capitalization of $32 million, has recently announced it has met ...
In 2024, Myriad Genetics was awarded three patents related to foundational platform MRD technology and cell-free DNA preparation methods that each enable highly sensitive and specific tumor-informed, ...